DISEASE SCANNER
Global Incurable Diseases Tracker
Hepatitis A
A highly contagious, vaccine-preventable liver infection caused by hepatitis A virus. Transmitted through fecal-oral route, typically via contaminated food/water or close contact. Usually self-limited with full recovery and no chronic infection. Common in areas with poor sanitation.
1.5M
111
Symptoms
Treatment Options
Risk Factors
Diagnostic Methods
- 1HAV IgM antibody (acute infection)
- 2HAV IgG antibody (past infection/immunity)
- 3Liver function tests
- 4Bilirubin levels
- 5PT/INR
Prognosis
Excellent; self-limited illness with complete recovery in 99% of cases. No chronic carrier state. Mortality <0.5% (higher in adults and those with chronic liver disease). Lifelong immunity after infection. Rarely causes acute liver failure.
Prevention
- Hepatitis A vaccination
- Hand washing
- Safe food/water practices
- Immune globulin (post-exposure)
- Travel precautions
Research Status
Highly effective vaccines (HAVRIX, VAQTA) since 1990s provide lifelong immunity. Immune globulin for post-exposure prophylaxis. Treatment is supportive; no specific antiviral. Vaccination of high-risk groups and universal childhood vaccination effective. Outbreaks continue among unvaccinated populations.
Affected Countries
Sources
- https://www.cdc.gov/hepatitis/hav/index.htm
- https://www.who.int/news-room/fact-sheets/detail/hepatitis-a
- https://www.niddk.nih.gov/health-information/liver-disease/viral-hepatitis/hepatitis-a
Medical Disclaimer
This information is for educational purposes only. Always consult healthcare professionals for medical advice, diagnosis, and treatment.